⇒ Kim Cousineau, MPA – President
⇒ Gary Conn – Vice President
⇒ Donald J. Michaud, MBA – Treasurer
⇒ Shaun Hindley, MS – Secretary
Directors (in alphabetical order)
⇒ Mark Asma
⇒ Dr. Robert “Ross” Coleman, MD
– Dr. Coleman, MD, is a neurologist specializing in movement disorders. Dr. Coleman earned his medical degree from Vanderbilt University School of Medicine in Nashville, Tennessee, and completed his neurology residency at the University of Michigan Health System in Ann Arbor. He completed his movement disorders fellowship at the University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center. Dr. Coleman’s clinical interests include Parkinson’s Disease (PD), essential tremor and other tremor disorders, dystonia, deep brain stimulation, levodopa intestinal infusion therapy, botulinum toxin injection, ataxia, Huntington’s disease, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, and other movement disorders.
⇒ Joy Gianakura, EdD
⇒ Dr. Barbara Pickut, MD
– Dr. Barbara Pickut is an Associate Professor of Neurology at the Michigan State University College of Human Medicine and College of Osteopathic Medicine. She is a graduate from the University of Michigan School of Public Health and received her medical degree from the University of Antwerp, Belgium where she completed residencies in Neurology and in Neuro-rehabilitation. She was a founding member of the Belgian Movement Disorders Society.
– Dr. Pickut has participated in clinical research studies for neurological diseases such as Parkinson’s and Alzheimer’s. She currently practices in East Lansing and specializes in Parkinson’s, Movement Disorders, Memory Disorders and clinical research.
⇒ Scott Pierce
⇒ Caryl Sortwell, PhD
– Dr. Caryl Sortwell’s research investigates therapeutic strategies for the treatment of PD including transplantation, pharmacotherapy, trophic factor augmentation via gene therapy and deep brain stimulation. Particular emphasis is placed on characterizing the time course and magnitude of nigrostriatal degeneration and functional impairment produced by a variety of insults in rat models of PD. These same rat models are then utilized to determine the potential of various neuroprotective approaches to slow degeneration. Dr. Sortwell is also interested in understanding how the aging brain environment impacts therapeutic strategies for PD.
⇒ Brian Toronyi
Emeritus (in alphabetical order)
⇒ Betsy Borre
⇒ Don Butcher
⇒ Dr. Leslie Neuman
⇒ Kurt Stiansen